Compare ASTRAZENECA PHARMA with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA VENUS REMEDIES ASTRAZENECA PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 98.9 6.7 1,476.2% View Chart
P/BV x 25.4 1.3 1,987.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ASTRAZENECA PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-20
VENUS REMEDIES
Mar-20
ASTRAZENECA PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs2,94037 7,872.7%   
Low Rs1,63520 8,386.2%   
Sales per share (Unadj.) Rs332.7276.7 120.2%  
Earnings per share (Unadj.) Rs28.9-8.1 -356.5%  
Cash flow per share (Unadj.) Rs36.317.8 203.6%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs145.1262.1 55.4%  
Shares outstanding (eoy) m25.0012.34 202.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.90.1 6,692.8%   
Avg P/E ratio x79.2-3.5 -2,257.6%  
P/CF ratio (eoy) x63.01.6 3,953.0%  
Price / Book Value ratio x15.80.1 14,529.7%  
Dividend payout %3.50-   
Avg Mkt Cap Rs m57,197351 16,303.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,167460 470.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,3183,415 243.6%  
Other income Rs m13053 244.7%   
Total revenues Rs m8,4483,468 243.6%   
Gross profit Rs m1,207320 377.1%  
Depreciation Rs m186320 58.0%   
Interest Rs m11133 8.5%   
Profit before tax Rs m1,140-80 -1,418.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m41820 2,126.3%   
Profit after tax Rs m722-100 -722.2%  
Gross profit margin %14.59.4 154.8%  
Effective tax rate %36.6-24.4 -149.9%   
Net profit margin %8.7-2.9 -296.4%  
BALANCE SHEET DATA
Current assets Rs m5,8222,880 202.2%   
Current liabilities Rs m3,6712,185 168.0%   
Net working cap to sales %25.920.3 127.2%  
Current ratio x1.61.3 120.4%  
Inventory Days Days4338 112.2%  
Debtors Days Days37328 11.1%  
Net fixed assets Rs m1,9353,498 55.3%   
Share capital Rs m50123 40.5%   
"Free" reserves Rs m3,5793,110 115.1%   
Net worth Rs m3,6293,234 112.2%   
Long term debt Rs m0721 0.0%   
Total assets Rs m7,7576,377 121.6%  
Interest coverage x101.00.4 25,399.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.10.5 200.3%   
Return on assets %9.50.5 1,806.6%  
Return on equity %19.9-3.1 -643.6%  
Return on capital %31.71.3 2,366.0%  
Exports to sales %00-   
Imports to sales %37.00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,080NA-   
Fx inflow Rs m3050-   
Fx outflow Rs m3,0800-   
Net fx Rs m-2,7750-   
CASH FLOW
From Operations Rs m874770 113.5%  
From Investments Rs m-1,708-47 3,597.3%  
From Financial Activity Rs m-64-730 8.7%  
Net Cashflow Rs m-897-7 13,100.7%  

Share Holding

Indian Promoters % 0.0 35.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.4 0.0 8,400.0%  
FIIs % 2.4 0.0 6,075.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 64.1 39.0%  
Shareholders   63,753 13,829 461.0%  
Pledged promoter(s) holding % 0.0 18.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   HINDUSTAN BIOSCIE  EMMESSAR CHM  SYSCHEM (I).  KILITCH DRUGS  FERMENTA BIOTECH  

Compare ASTRAZENECA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Maruti Suzuki and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity today and ended on a flat note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained(Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jun 22, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - MESCO PHARMA COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS